تحذيرات السلامة

#	العنوان	نوع الخبر	التاريخ
78	Safety Signal of Rhabdomyolysis associated with the use of Pembrolizumab	Signal	2020-09-07
77	Safety Signal of Baricitinib and the Potential Risk of Diverticulitis	Signal	2020-03-25
76	Safety Signal of Cardiac Failure associated with the use of Ibrutinib	Signal	2020-08-02
75	Safety Signal of Skin Cancer associated with the use of Methotrexate	Signal	2020-09-07
74	Switching between Warfarin Brands and The Importance of Close Monitoring of INR	Precautions	2020-06-09
73	Hydroxychloroquine and Chloroquine Alone and in Combination with Azithromycin and Potential Increased Risk of Heart Rhythm Problems	Warning	2020-05-11
72	SFDA Recommendations for Healthcare Professionals Regarding The Unapproved Use of Hydroxychloroquine and Chloroquine in Treatment of COVID-19	Warning	2020-04-24
71	SFDA Advises Continued Use of Angiotensin-Converting Enzyme (ACE) Inhibitors and Angiotensin Receptor Blockers (ARBs) in Patients with COVID-19	Precautions	2020-04-14
70	SFDA’s Advice on the Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) in Patients with COVID-19	Precautions	2020-03-31
69	Risk of potentially fatal respiratory depression with benzodiazepines and opioids	Warning	2020-03-22